Cutaneous complications of molecular targeted therapy used in oncology

The new molecular targeted therapy has been developed over the past decades by using the molecular targeted molecular changes discovered in specific types of cancer. Unfortunately, most of these agents (epidermal growth factor receptors, multi-targeted small molecule tyrosine kinase inhibitors, mono...

Descripción completa

Detalles Bibliográficos
Autores principales: Lupu, I, Voiculescu, N, Bacalbasa, N, Cojocaru, I, Vrancian, V, Giurcaneanu, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Carol Davila University Press 2016
Materias:
General Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152604/
https://www.ncbi.nlm.nih.gov/pubmed/27974909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152604/
https://www.ncbi.nlm.nih.gov/pubmed/27974909

Ejemplares similares